Ischemic Heart Disease in Chronic Hepatitis B: A Danish Nationwide Cohort Study

References

• Beasley RP. Hepatitis B virus. The major etiology of hepatocellular carcinoma. Cancer. 1988;61(10):1942–1956. doi:10.1002/1097-0142(19880515)61:10<1942::aid-cncr2820611003>3.0.co;2-j
   PubMed Web of Science ®Google Scholar
• Seto WK, Lo YR, Pawlotsky JM, Yuen MF. Chronic hepatitis B virus infection. Lancet. 2018;392(10161):2313–2324. doi:10.1016/S0140-6736(18)31865-8
   PubMed Web of Science ®Google Scholar
• Andersen E, Omland L, Jepsen P, et al. Risk of all-type cancer, hepatocellular carcinoma, non-Hodgkin lymphoma and pancreatic cancer in patients infected with hepatitis B virus. J Viral Hepat. 2015;22(10):828–834. doi:10.1111/jvh.12391
   PubMed Web of Science ®Google Scholar
• Amin J, Dore GJ, O’Connell DL, et al. Cancer incidence in people with hepatitis B or C infection: a large community-based linkage study. J Hepatol. 2006;45(2):197–203. doi:10.1016/j.jhep.2006.02.014
   PubMed Web of Science ®Google Scholar
• Ganem D, Prince AM. Hepatitis B virus infection–natural history and clinical consequences. N Engl J Med. 2004;350(11):1118–1129. doi:10.1056/NEJMra031087
   PubMed Web of Science ®Google Scholar
• Shah ASV, Stelzle D, Lee KK, et al. Global burden of atherosclerotic cardiovascular disease in people living with HIV: systematic review and meta-analysis. Circulation. 2018;138(11):1100–1112. doi:10.1161/CIRCULATIONAHA.117.033369
   PubMed Web of Science ®Google Scholar
• Lee KK, Stelzle D, Bing R, et al. Global burden of atherosclerotic cardiovascular disease in people with hepatitis C virus infection: a systematic review, meta-analysis, and modelling study. Lancet Gastroenterol Hepatol. 2019;4(10):794–804. doi:10.1016/S2468-1253(19
   PubMed Web of Science ®Google Scholar
• Pothineni NVK, Subramany S, Kuriakose K, et al. Infections, atherosclerosis, and coronary heart disease. Eur Heart J. 2017;38(43):3195–3201. doi:10.1093/eurheartj/ehx362
   PubMed Web of Science ®Google Scholar
• Kumar A, Shariff M, Doshi R. Association between past hepatitis B infection and ischemic heart disease: an analysis from the 2007–2016 NHANES data. Am J Med Sci. 2020;360(4):372–377. doi:10.1016/j.amjms.2020.05.034
   Web of Science ®Google Scholar
• Sung J, Song YM, Choi YH, Ebrahim S, Davey Smith G. Hepatitis B virus seropositivity and the risk of stroke and myocardial infarction. Stroke. 2007;38(5):1436–1441. doi:10.1161/STROKEAHA.106.466268
   Web of Science ®Google Scholar
• Momiyama Y, Ohmori R, Kato R, Taniguchi H, Nakamura H, Ohsuzu F. Lack of any association between persistent hepatitis B or C virus infection and coronary artery disease. Atherosclerosis. 2005;181(1):211–213. doi:10.1016/j.atherosclerosis.2005.02.027
   Web of Science ®Google Scholar
• Tong DY, Wang XH, Xu CF, Yang YZ, Xiong SD. Hepatitis B virus infection and coronary atherosclerosis: results from a population with relatively high prevalence of hepatitis B virus. World J Gastroenterol. 2005;11(9):1292–1296. doi:10.3748/wjg.v11.i9.1292
   Web of Science ®Google Scholar
• Ghotaslou R, Aslanabadi N, Ghojazadeh M. Hepatitis B virus infection and the risk of coronary atherosclerosis. Ann Acad Med Singap. 2008;37(11):913–915.
   Web of Science ®Google Scholar
• Katoonizadeh A, Ghoroghi S, Sharafkhah M, et al. Chronic hepatitis B infection is not associated with increased risk of vascular mortality while having an association with metabolic syndrome. J Med Virol. 2016;88(7):1230–1237. doi:10.1002/jmv.24466
   Web of Science ®Google Scholar
• Ishizaka N, Ishizaka Y, Takahashi E, et al. Increased prevalence of carotid atherosclerosis in hepatitis B virus carriers. Circulation. 2002;105(9):1028–1030. doi:10.1161/hc0902.105718
   PubMed Web of Science ®Google Scholar
• Hansen N, Obel N, Christensen PB, et al. Predictors of antiviral treatment initiation in hepatitis C virus-infected patients: a Danish cohort study. J Viral Hepat. 2009;16(9):659–665. doi:10.1111/j.1365-2893.2009.01126.x
   PubMed Web of Science ®Google Scholar
• Omland LH, Jepsen P, Skinhøj P, et al. The impact of HIV-1 co-infection on long-term mortality in patients with hepatitis C: a population-based cohort study. HIV Med. 2009;10(2):65–71. doi:10.1111/j.1468-1293.2008.00652.x
   Web of Science ®Google Scholar
• Lynge E, Sandegaard JL, Rebolj M. The Danish national patient register. Scand J Public Health. 2011;39(7 Suppl):30–33. doi:10.1177/1403494811401482
   PubMed Web of Science ®Google Scholar
• Juel K, Helweg-Larsen K. The Danish registers of causes of death. Dan Med Bull. 1999;46(4):354–357.
   Google Scholar
• Pedersen CB. The Danish civil registration system. Scand J Public Health. 2011;39(7 Suppl):22–25. doi:10.1177/1403494810387965
   PubMed Web of Science ®Google Scholar
• Hansen N, Hay G, Cowan S, et al. Hepatitis B prevalence in Denmark – an estimate based on nationwide registers and a national screening programme, as on 31 December 2007. Eurosurveillance. 2013;18(47):20637. doi:10.2807/1560-7917.ES2013.18.47.20637
   Web of Science ®Google Scholar
• Islam MF, Wu J, Jansson J, Wilson D. Relative risk of cardiovascular disease among people living with HIV: a systematic review and meta-analysis. HIV Med. 2012;13(8):453–468. doi:10.1111/j.1468-1293.2012.00996.x
   PubMed Web of Science ®Google Scholar
• Criteria I of M (US) C on SSCD. Ischemic Heart Disease. National Academies Press (US); 2010. Available from: https://www.ncbi.nlm.nih.gov/books/NBK209964/. Accessed May 27, 2021.
   Google Scholar
• Thygesen SK, Christiansen CF, Christensen S, Lash TL, Sørensen HT. The predictive value of ICD-10 diagnostic coding used to assess Charlson comorbidity index conditions in the population-based Danish National Registry of Patients. BMC Med Res Methodol. 2011;11(1):83. doi:10.1186/1471-2288-11-83
   PubMed Web of Science ®Google Scholar
• Joensen AM, Jensen MK, Overvad K, et al. Predictive values of acute coronary syndrome discharge diagnoses differed in the Danish National Patient Registry. J Clin Epidemiol. 2009;62(2):188–194. doi:10.1016/j.jclinepi.2008.03.005
   Web of Science ®Google Scholar
• Quan H, Li B, Couris CM, et al. Updating and validating the Charlson comorbidity index and score for risk adjustment in hospital discharge abstracts using data from 6 countries. Am J Epidemiol. 2011;173(6):676–682. doi:10.1093/aje/kwq433
   PubMed Web of Science ®Google Scholar
• SDG Indicators — SDG Indicators. Available from: https://unstats.un.org/sdgs/indicators/regional-groups. Accessed August 20, 2021.
   Google Scholar
• UNSD — Methodology. Available from: https://unstats.un.org/unsd/methodology/m49/. Accessed August 20, 2021.
   Google Scholar
• Stata: Software for statistics and data science. Available from: https://www.stata.com/. Accessed August 21, 2021.
   Google Scholar
• RStudio | Open source & professional software for data science teams. Available from: https://rstudio.com/. Accessed August 21, 2021.
   Google Scholar
• Tang LSY, Covert E, Wilson E, Kottilil S. Chronic hepatitis B infection: a review. JAMA. 2018;319(17):1802–1813. doi:10.1001/jama.2018.3795
   PubMed Web of Science ®Google Scholar
• Yu Y, Gong R, Mu Y, et al. Hepatitis B virus induces a novel inflammation network involving three inflammatory factors, IL-29, IL-8, and cyclooxygenase-2. J Immunol. 2011;187(9):4844–4860. doi:10.4049/jimmunol.1100998
   Web of Science ®Google Scholar
• Si J, Yu C, Guo Y, et al. Chronic hepatitis B virus infection and total and cause-specific mortality: a prospective cohort study of 0.5 million people. BMJ Open. 2019;9(4):e027696. doi:10.1136/bmjopen-2018-027696
   PubMed Web of Science ®Google Scholar
• Epstein SE, Zhu J, Najafi AH, Burnett MS. Insights into the role of infection in atherogenesis and in plaque rupture. Circulation. 2009;119(24):3133–3141. doi:10.1161/CIRCULATIONAHA.109.849455
   Web of Science ®Google Scholar
• Hao S, Wang Y, Gao G, Hepatitis LZ. B virus upregulates the expression of C-reactive protein both in vivo and in vitro. Ann Clin Lab Sci. 2017;47(4):432–435.
   Web of Science ®Google Scholar
• Marchesini G, Ronchi M, Forlani G, et al. Cardiovascular disease in cirrhosis–a point-prevalence study in relation to glucose tolerance. Am J Gastroenterol. 1999;94(3):655–662. doi:10.1111/j.1572-0241.1999.00931.x
   Web of Science ®Google Scholar
• Joo EJ, Chang Y, Yeom JS, Ryu S. Hepatitis B virus infection and decreased risk of nonalcoholic fatty liver disease: a cohort study. Hepatology. 2017;65(3):828–835. doi:10.1002/hep.28917
   PubMed Web of Science ®Google Scholar
• Meade TW, Stirling Y, Thompson SG, Ajdukiewicz A, Barbara JAJ, Chalmers DM. Carriers of hepatitis B surface antigen: possible association between low levels of clotting factors and protection against ischaemic heart disease. Thromb Res. 1987;45(5):709–713. doi:10.1016/0049-3848(87)90336-7
   Web of Science ®Google Scholar
• Razi B, Alizadeh S, Omidkhoda A, Imani D, Rezaei R. Association of chronic hepatitis B infection with metabolic syndrome and its components: meta-analysis of observational studies. Diabetes Metab Syndr. 2017;11(Suppl 2):S939–S947. doi:10.1016/j.dsx.2017.07.020
   Web of Science ®Google Scholar
• Wijarnpreecha K, Thongprayoon C, Panjawatanan P, Ungprasert P. Hepatitis B virus infection and risk of coronary artery disease: a meta-analysis. Ann Transl Med. 2016;4(21):423. doi:10.21037/atm.2016.11.12
   Web of Science ®Google Scholar
• Wang Y, Xiong J, Niu M, Xu W, Xu K, Zhong H. Hepatitis B virus and the risk of coronary heart disease: a comprehensive systematic review and meta-analyses of observational studies. Int J Cardiol. 2018;265:204–209. doi:10.1016/j.ijcard.2018.04.059
   Web of Science ®Google Scholar